Position in PFE
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$11,342,932
-$4,452,994 QoQ
Shares Held
471,052
-16.3% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.86%
of 13F equity value
Holder Rank
#388
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Callahan Advisors, LLC holds $70,085,621 across 7 Drug Manufacturers - General names. PFE ranks #3 (16.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
106,466 | $27,039,170 | |
| 2 | LLY |
ELI LILLY & Co
|
21,791 | $26,136,781 | |
| 3 | PFE |
Pfizer Inc
This page
|
471,052 | $11,342,932 | |
| 4 | MRK |
Merck & Co., Inc.
|
22,700 | $2,916,950 | |
| 5 | ABBV |
AbbVie Inc.
|
5,488 | $1,381,000 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
15,089 | $869,428 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,161 | $399,360 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,342,932 | 471,052 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $15,795,926 | 562,533 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $15,630,178 | 627,718 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $18,187,547 | 713,797 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $16,249,114 | 670,343 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $14,583,093 | 575,497 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $12,954,439 | 488,294 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $12,129,882 | 419,139 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $10,782,848 | 385,377 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $8,081,826 | 291,237 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $6,184,322 | 214,808 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $9,994,353 | 301,307 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $11,783,376 | 321,248 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $12,998,308 | 318,586 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $17,552,569 | 342,556 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $15,681,614 | 358,355 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $19,259,898 | 367,345 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $19,821,645 | 382,879 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $23,372,108 | 395,802 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $15,429,536 | 358,743 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $13,472,488 | 344,037 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $12,289,868 | 339,218 | Shares | Sole | 2021-04-21 | |
| 2020-12-31 | $12,248,821 | 332,758 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $12,418,460 | 338,378 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $11,011,507 | 336,743 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $10,584,321 | 324,275 | Shares | Sole | 2020-04-06 | |
| No filing history on record for this holder in this stock. | ||||||